Paroxetine, sertraline, and fluvoxamine: New selective serotonin reuptake inhibitors

Keyphrases

• Selective Serotonin Reuptake Inhibitors 100%
• Fluvoxamine 100%
• Sertraline 100%
• Paroxetine 100%
• Depression Treatment 66%
• Placebo 66%
• Adverse Effects 50%
• Amitriptyline 33%
• Clomipramine 33%
• Imipramine 33%
• Drug Interactions 16%
• Pharmacology 16%
• Nausea 16%
• Volume of Distribution 16%
• Plasma Proteins 16%
• Desipramine 16%
• Pharmacokinetics 16%
• Pharmacokinetic Profile 16%
• Insomnia 16%
• Elderly Patients 16%
• Elimination Half-life 16%
• Drug Dosage 16%
• Drug Efficacy 16%
• Sedation 16%
• Headache 16%
• Fluoxetine 16%
• Large Volume 16%
• Constipation 16%
• Antidepressant Therapy 16%
• Obsessive-compulsive Disorder 16%
• Clinical Experience 16%
• Doxepin 16%
• Maprotiline 16%
• Mianserin 16%
• Dry Mouth 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Selective Serotonin Reuptake Inhibitor 100%
• Fluvoxamine 100%
• Paroxetine 100%
• Sertraline 100%
• Placebo 66%
• Clomipramine 33%
• Amitriptyline 33%
• Imipramine 33%
• Pharmacokinetics 33%
• Antidepressant 16%
• Headache 16%
• Nausea 16%
• Adverse Event 16%
• Elimination 16%
• Volume of Distribution 16%
• Drug Interaction 16%
• Desipramine 16%
• Plasma Protein 16%
• Constipation 16%
• Fluoxetine 16%
• Obsessive Compulsive Disorder 16%
• Maprotiline 16%
• Doxepin 16%
• Xerostomia 16%
• Mianserin 16%